Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

The economic costs of Group B Streptococcus (GBS) disease : prospective cohort study of infants with GBS disease in England

Tools
- Tools
+ Tools

Schroeder, Elizabeth-Ann, Petrou, Stavros, Balfour, Gail, Edamma, Oya and Heath, Paul T.. (2009) The economic costs of Group B Streptococcus (GBS) disease : prospective cohort study of infants with GBS disease in England. European Journal of Health Economics, Vol.10 (No.3). pp. 275-285. ISSN 1618-7598

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1007/s10198-008-0131-4

Abstract

The objective of this study was to estimate the economic costs over the first 2 years of life of Group B Streptococcus (GBS) disease occurring in infants less than 90 days of age. A cost analysis was conducted using a prospective cohort of children born between 2000 and 2003 in the Greater London, Oxford, Portsmouth and Bristol areas of England. Unit costs were applied to estimates of the health and social resource use made by 138 infants diagnosed with GBS disease and 305 non-GBS controls matched for birth weight and hospital stay and time of birth. The health and social care costs for infants exposed to GBS disease were analysed in a multiple linear regression model. The mean health and social care cost over the first 2 years of life was estimated at £11,968.9 for infants with GBS, compared to £6,260.7 for the non-GBS controls; a mean cost difference of £5,708.1 (bootstrap 95% CI £2,977.1, £8,391.2, P = 0.03). After adjusting for gestational age and other potential confounders in a multiple linear regression, mean societal costs was £6,144.7 higher among GBS cases than among non-GBS controls (P < 0.001). This study shows that the health and social care costs for infants with GBS disease is, on average, two-fold higher during the first 2 years of life than for infants without GBS disease. These data should be used to inform policy decisions regarding the cost-effectiveness of prevention and treatment strategies for GBS disease during early childhood.

Item Type: Journal Article
Subjects: Q Science > QR Microbiology
R Medicine > R Medicine (General)
R Medicine > RJ Pediatrics
Divisions: Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Streptococcus agalactiae -- Treatment -- England, Children -- Diseases -- Treatment -- England, Medical economics
Journal or Publication Title: European Journal of Health Economics
Publisher: Springer
ISSN: 1618-7598
Date: 2009
Volume: Vol.10
Number: No.3
Page Range: pp. 275-285
Identification Number: 10.1007/s10198-008-0131-4
Status: Not Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Meningitis Research Foundation (MRF)
URI: http://wrap.warwick.ac.uk/id/eprint/37031

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us